Zigong Honghe Pharmaceutical

Zigong Honghe Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer and a subsidiary of the Kelun Pharmaceutical Group. Based in Zigong, Sichuan, the company is a leading global producer of aminoglycoside antibiotics, including Gentamicin Sulfate, Kanamycin Sulfate, and Tobramycin. Its operations focus on the large-scale production of Active Pharmaceutical Ingredients (APIs) and finished sterile injections in compliance with international GMP standards. The company plays a critical role in the supply chain for anti-infective medications, serving both the Chinese domestic market and international export markets. Originally established as a state-owned enterprise in 1958, it has evolved into a modernized production base for chemical drugs and traditional Chinese medicine. The facility is recognized for its fermentation and synthesis capabilities, supporting Kelun's broader strategy in the antibiotic sector.